In the News Archives - Yomi By Neocis

April 22, 2026 by Khue Bui

Press Release

Neocis and Yomi® S Named Winner of the 2026 TAG Awards for MedTech in Robotic & Procedural Innovation

Miami, FL — April 22, 2026 — Neocis®, the company behind the first and only FDA-cleared robotic system for dental implant surgery, today announced that Yomi® S has been named a winner of the 2026 TAG Awards for MedTech in the category of Medical Devices: Robotic & Procedural Innovation. The TAG Awards, produced by The Aebli Group, recognize companies advancing what is possible across MedTech, Life Sciences, and BioTech.

Honorees are selected by experienced industry judges based on design, real-world relevance, market value, and demonstrated potential to improve outcomes across the healthcare landscape. Yomi S was recognized for its groundbreaking approach to dental implant surgery — setting a new standard for precision, efficiency, and patient care.

“Yomi S is a groundbreaking innovation in dental implant surgery, setting a new standard for precision, efficiency, and patient care. With over 100,000 procedures completed and FDA clearance in place, the system demonstrates both clinical validation and real-world adoption, while addressing growing access challenges in oral surgery.”

— TAG Awards Judge

“This recognition reflects the vision and hard work of the entire Neocis team,” said Alon Mozes, CEO of Neocis. “Yomi S was designed to revolutionize dental robotics with true physical AI, making robotic surgery more accessible, more intuitive, and more impactful for both clinicians and patients. Being recognized by the TAG Awards alongside some of the most innovative companies in MedTech is a testament to what this platform can do.”

The Next Generation of Robotic Dental Surgery

Yomi S builds on the proven foundation of the original Yomi platform — which has now guided over 100,000 osteotomies — with a redesigned system that integrates AI-powered planning, an ergonomic single-surgeon workflow, and an intuitive multimodal interface. Yomi S and Yomi are the only FDA-cleared dental robots that turn clinical precision into practice advantage. Key capabilities include:

AI-powered planning tools that automatically detect nerves, sinuses, and enable advanced restorative planning including custom crown design for every patient
Integrated drill console enabling speed, torque, and irrigation control from one centralized platform
Single-surgeon workflows with voice, gesture, foot pedal, and touchscreen controls that reduce staffing needs and training time
Ergonomic, space-saving design built to fit comfortably into the operatory

Availability

Yomi S is FDA-cleared and commercially available in the U.S.

About Yomi

The Yomi Robotic System (Yomi) is a computerized robotic navigational system intended to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and offers robotic navigational guidance of the surgical instruments. Yomi can be used for adult patients who qualify for dental implants, including alveoplasty and implant surgery for partially edentulous and fully edentulous patients.

About Neocis

Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from top investors including NVIDIA’s NVentures, Intuitive Surgical’s Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, and surgical robotics pioneer Fred Moll.

Contact

For more information, visit www.neocis.com or contact Neocis Media Relations at info@neocis.com

March 12, 2026 by Khue Bui

Yomi Robotic Guidance Highlighted in Live Implant Surgery Demonstration

Dentistry Today | March 11, 2026

Dentistry Today attended a live surgical demonstration featuring Jay Neugarten, DDS, MD, FACS, performing robotic-assisted implant placement using the Yomi S robotic guidance system.

The presentation highlighted the evolution of implant placement techniques—from traditional freehand surgery to guided systems and now robotic-assisted technology that allows clinicians to translate digital treatment planning directly into the surgical environment with enhanced precision and control.

Advancing dental robotics: Neocis discusses the next phase of the Yomi S system

By Isabel Siew | Dental Asia

Alon Mozes, founder and chief executive officer of Neocis, has provided an in-depth perspective on the development of Yomi S, the company’s latest robotic assisted surgical platform. The updated system introduces new hardware, an AI-supported planning interface, and enhanced workflow features designed to address both clinical and operational challenges identified with the original Yomi model.

The original Yomi system was notable for integrating visual, audio, and haptic guidance to support precise, minimally invasive dental implant procedures. While effective, its design often required the presence of an additional assistant to input commands and facilitate communication during surgery. This requirement could complicate clinical workflow and add operational complexity, particularly in practices with limited staff. Yomi S seeks to overcome these challenges by embedding greater intelligence and user interface capabilities, enabling single-operator use and streamlining the overall workflow.

Early integration of robotic-assisted implant surgery to accelerate associate productivity and practice growth

Leo Haydt, DDS, Robert B. Bryan, DDS, FACD, FACS, Reinol Gonzalez, DMD, FICOI, Michael Costa, DDS, MHA

The case studies reveal that adopting Yomi technology enables practices to increase implant procedures, improve efficiency, and differentiate themselves in competitive markets, ultimately leading to faster revenue generation and expanded service offerings.

Headshots of Drs. Fuller, Fajardo, Bryant, and Wolkow — Associates studied in this case study: Drs. Fuller, Fajardo, Bryant, and Wolkow

Key Highlights

Robotic guidance shortens the learning curve for new associates, enabling immediate contribution to implant procedures.
Yomi’s intraoperative flexibility allows for same-day planning and surgery, increasing case volume and efficiency.
Practices using Yomi experience significant growth in implant volume and full-arch procedures, often exceeding 50% increases.
The technology enhances accuracy, reduces complications, and serves as a marketing differentiator to attract more patients.
Adopting robotic systems like Yomi can strategically transform a practice’s growth trajectory and competitive positioning.

Neocis Surpasses 100,000 Robotic Osteotomies with the Yomi Platform

Landmark milestone demonstrates proven robotic adoption as the next generation Yomi S completes the first real world cases.

Watch our video on Instagram

Get a Yomi demo today

MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — Neocis, the market leader behind the Yomi® robotic dental implant system, today announced that clinicians have completed more than 100,000 osteotomies using the Yomi platform, marking a significant milestone in the real-world adoption of robotic assistance in implant dentistry.Neocis also confirmed that the first clinical cases using Yomi S, its second-generation robotic system, have now been successfully completed by Dr. Jay Neugarten, DDS, MD, FACS. The initial procedures signal the new platform’s transition to clinical reality, reinforcing Neocis’ ability to translate innovation into deployable technology while building on the proven foundation established by more than 100,000 Yomi-guided osteotomies.The achievement reflects sustained clinical use of Yomi across a broad range of implant indications and practice settings, underscoring the platform’s role in supporting precision, consistency, and confidence during dental implant surgeries.

“Reaching 100,000 osteotomies is more than just a statistical achievement — it represents clinicians across the country choosing to integrate robotics into their daily surgical workflow,” said Alon Mozes, Chief Executive Officer and co-founder of Neocis. “This level of usage demonstrates trust in the technology and reinforces our belief that robotics has set a new standard of care.”

Yomi is the first and only FDA-cleared robotic system for dental implant surgery, and Yomi S was recently announced in 2025 as the second generation system. The platform combines real-time haptic guidance, pre-operative digital planning, and intra-operative adaptability to assist clinicians during implant cases. Since its introduction, Yomi has been used in a wide variety of cases, from single-tooth to full-arch implant procedures.

“Clinicians are increasingly seeking technologies that integrate seamlessly into existing workflows while delivering tangible procedural value,” said Dennis Moses, Chief Technology Officer of Neocis. “The scale reflected in 100,000 osteotomies validates both the robustness of the platform and its proven ability to perform consistently across real-world clinical environments.”

Neocis continues to invest in expanding Yomi’s capabilities through software enhancements, workflow optimization, and advanced planning tools designed to support efficient case execution and broaden clinical applications.

The 100,000-osteotomy milestone represents another step forward in Neocis’ mission to advance robotic innovation in dentistry and support clinicians everywhere in delivering high-quality implant care.

About Neocis
Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians to develop innovative technologies that help advance patient care and improve quality of life. Based in Miami, Neocis is venture-backed with funding from Mirae Asset Financial Group, NVentures, Intuitive Ventures, DFJ Growth, Mithril Capital Management, Norwest Venture Partners, Vivo Capital, Section 32, and surgical robotics pioneer Fred Moll. For more information, visit neocis.com.

Contact
For more information, please contact the Neocis media relations team at info@neocis.com.

November 18, 2025 by Khue Bui

Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants

November 18, 2025 | Tuesday | MedTech Spectrum

Yomi S and YomiPlan AI Platform Now FDA-Cleared, Offering Unprecedented Precision, Efficiency, and Access for Dentists and Patients

Neocis, the pioneer behind the first and only U.S. FDA-cleared robotic system for dental implant surgery, announced the launch and FDA approval of its next-generation robotic platform: Yomi S. The new system, powered by advanced AI software YomiPlan, redefines what’s possible in dental surgery—delivering surgical precision, streamlined workflows, and high-quality patient outcomes.

Designed for maximum efficiency and minimal invasiveness, Yomi S can now be operated by a single practitioner via foot pedal and touchscreen—freeing up staff resources and making robotic-assisted implant surgery more accessible to general dentists. The system features a smaller footprint, enhanced dexterity, better visibility, and a new AI-powered planning suite that automates complex preoperative tasks.